The commensal urinary microbiome as a predictor of response to Bacillus Calmette-Guerin (BCG) immunotherapy in non-muscle invasive bladder cancer

被引:0
|
作者
Sweis, Randy F. [1 ]
Golan, Shay [2 ]
Barashi, Nimrod [1 ]
Hill, Elle [1 ]
Andolfi, Ciro [1 ]
Werntz, Ryan [1 ]
Bloodworth, Jeffrey [1 ]
Gajewski, Thomas [1 ]
Steinberg, Gary D. [1 ]
机构
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Rabin Med Ctr, Petah Tiqwa, Israel
关键词
D O I
10.1158/1538-7445.SABCS18-2836
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2836
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Association of the commensal urinary microbiome with response to Bacillus Calmette-Guerin (BCG) immunotherapy in nonmuscle invasive bladder cancer.
    Sweis, Randy F.
    Golan, Shay
    Barashi, Nimrod
    Hill, Elle
    Andolfi, Ciro
    Werntz, Ryan P.
    Bloodworth, Jeffrey
    Steinberg, Gary D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [2] CHARACTERIZATION OF THE URINARY MICROBIOME IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY
    Sweis, Randy
    Golan, Shay
    Barashi, Nimrod
    Hill, Elle
    Andolfi, Ciro
    Bloodworth, Jeffrey
    Werntz, Ryan
    Steinberg, Gary
    [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E621 - E621
  • [3] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
    Wang, Ziting
    So, Wei Zheng
    Loh, Kep Yong
    Lim, Yew Koon
    Mahendran, Ratha
    Wu, Qing Hui
    Chiong, Edmund
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
  • [4] Role of immunotherapy in Bacillus Calmette-Guerin unresponsive: non-muscle invasive bladder cancer
    Suh, Jungyo
    Yoo, Sangjun
    [J]. TRANSLATIONAL CANCER RESEARCH, 2020, 9 (10) : 6537 - 6545
  • [5] Methylation status as a predictor of intravesical Bacillus Calmette-Guerin (BCG) immunotherapy response of high grade non-muscle invasive bladder tumor
    Husek, Petr
    Pacovsky, Jaroslav
    Chmelarova, Marcela
    Podhola, Miroslav
    Brodak, Milos
    [J]. BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 (02): : 210 - 216
  • [6] Variation in the commensal urinary microbiome is associated with response to Bacillus Calmette-Guerin (BCG) immunotherapy in early stage urothelial bladder cancer
    Sweis, Randy
    Andolfi, Ciro
    Bloodworth, Jeffrey
    Golan, Shay
    Barashi, Nimrod
    Hill, Elle
    Werntz, Ryan
    Gajewski, Thomas
    Steinberg, Gary
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [7] Bacillus Calmette-Guerin treatment of non-muscle invasive bladder cancer
    Sylvester, Richard J.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (02) : 113 - 120
  • [8] Intravesical Thalidomide boosts bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer treatment
    Passos, Gabriela R.
    Camargo, Juliana A.
    Ferrari, Karen L.
    Saad, Mario J. A.
    de Mattos, Amilcar C.
    Reis, Leonardo O.
    [J]. MEDICAL ONCOLOGY, 2018, 35 (01)
  • [9] Impact of intravesical Bacillus Calmette-Guerin and chemotherapy on the bladder microbiome in patients with non-muscle invasive bladder cancer
    James, Christopher
    Gomez, Kayeromi
    Desai, Shalin
    Patel, Hiten D.
    Rac, Goran
    Doshi, Chirag P.
    Dornbier, Ryan
    Bajic, Petar
    Halverson, Thomas
    Gupta, Gopal N.
    Quek, Marcus L.
    Gorbonos, Alex
    Flanigan, Robert
    Wolfe, Alan J.
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [10] Immunotherapy with cancer peptides in combination with intravesical bacillus Calmette-Guerin for patients with non-muscle invasive bladder cancer
    Obara, Wataru
    Hara, Isao
    Kato, Yoichiro
    Kato, Renpei
    Inoue, Keiji
    Sato, Fuminori
    Mimata, Hiromitsu
    Nakamura, Yusuke
    Fujioka, Tomoaki
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (09) : 1371 - 1380